0 TSX News - February 29, 2024HEALWELL AI Files Base Shelf ProspectusNOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, Feb. 29, 2024 (GLOBE […]Read More
0 NYSE Companies - February 29, 2024CubeSmart Reports Fourth Quarter and Annual 2023 ResultsMALVERN, Pa., Feb. 29, 2024 (GLOBE NEWSWIRE) — CubeSmart (NYSE: CUBE) today announced its operating results for the three and […]Read More
0 NYSE Companies - February 29, 2024FG Financial Group, Inc. and FG Group Holdings Inc. Complete MergerFG Financial Group, Inc. Renamed to Fundamental Global Inc.New Leadership and Governance Structure in Place Mooresville, NC, Feb. 29, 2024 […]Read More
0 NYSE Companies - February 29, 2024Black Hills Corp. Announces Investor Meetings and Reaffirms GuidanceRAPID CITY, S.D., Feb. 29, 2024 (GLOBE NEWSWIRE) — Black Hills Corp. (NYSE: BKH) today announced that members of its […]Read More
0 NYSE Companies - February 29, 2024Kite Realty Group Trust to Present at the Citi 2024 Global Property CEO ConferenceINDIANAPOLIS, Feb. 29, 2024 (GLOBE NEWSWIRE) — Kite Realty Group Trust (NYSE: KRG) announced today that it will present at […]Read More
0 NASDAQ Companies - February 29, 2024Certara Reports Fourth Quarter 2023 Financial ResultsPRINCETON, N.J., Feb. 29, 2024 (GLOBE NEWSWIRE) — Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today reported its […]Read More
0 NASDAQ Companies - February 29, 2024Triumph Financial Announces Dividend for 7.125% Series C Fixed-Rate Non-Cumulative Perpetual Preferred StockDALLAS, Feb. 29, 2024 (GLOBE NEWSWIRE) — Triumph Financial, Inc. (the “Company”) (Nasdaq: TFIN) today announced that the Company’s Board […]Read More
0 NASDAQ Companies - February 29, 2024Cardiff Oncology Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update– First patient dosed in Phase 2 first-line trial in patients with RAS-mutated mCRC for new lead program with the […]Read More
0 NASDAQ Companies - February 29, 2024Cardiff Oncology Provides Clinical Update on Phase 2 Randomized Second-line ONSEMBLE Trial in Patients with RAS-mutated mCRC– New clinical data from second-line randomized ONSEMBLE trial provides further evidence of the efficacy of onvansertib in combination with […]Read More
0 NASDAQ Companies - February 29, 2024Gulf Island Announces Fourth Quarter and Full Year 2023 Results Conference Call DateTHE WOODLANDS, Texas, Feb. 29, 2024 (GLOBE NEWSWIRE) — Gulf Island Fabrication, Inc. (“Gulf Island” or the “Company”) (NASDAQ: GIFI), […]Read More